Identification and validation of an ERBB2 gene expression signature in breast cancers

Oncogene

Volumn 23, Issue 14, 2004, Pages 2564-2575

  Bertucci, François ^a,b   Borie, Nathalie ^c   Ginestier, Christophe ^a   Groulet, Agnès ^c   Charafe Jauffret, Emmanuelle ^a,b   Adélaïde, José ^a   Geneix, Jeannine ^a   Bachelart, Loïc ^a   Finetti, Pascal ^a   Koki, Alane ^c   Hermitte, Fabienne ^c   Hassoun, Jacques ^a,b   Debono, Stéphane ^c   Viens, Patrice ^a,b   Fert, Vincent ^c   Jacquemier, Jocelyne ^a   Birnbaum, Daniel ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c Ipsogen SA   (France)

Author keywords

Breast cancer; DNA microarrays; ERBB2 HER2; Expression profiles; FISH; Gene expression; Tissue microarrays

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CHROMOSOME 17Q; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MICROARRAY; DOWN REGULATION; ERBB2 GENE; EXPRESSED SEQUENCE TAG; GATA 4 GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; DOWN-REGULATION; EXPRESSED SEQUENCE TAGS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 11144355581     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207361     Document Type: Article

References (56)

1. Andersen CL, Monni O, Wagner U, Kononen J, Barlund M, Bucher C, Haas P, Nocito A, Bissig H, Sauter G and Kallioniemi A. (2002). Am. J. Pathol., 161, 73-79.
2. Arthur WT, Noren NK and Burridge K. (2002). Biol. Res., 35, 239-246.
3. Bertucci F, Houlgatte R, Benziane A, Granjeaud S, Adelaide J, Tagett R, Loriod B, Jacquemier J, Viens P, Jordan B, Birnbaum D and Nguyen C. (2000). Hum. Mol. Genet., 9, 2981-2991.
4. Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaide J, Tagett R, Loriod B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum D and Houlgatte R. (2002). Hum. Mol. Genet., 11, 863-872.
5. Bertucci F, Viens P, Hingamp P, Nasser V, Houlgatte R and Birnbaum D. (2003a). Int. J. Cancer, 103, 565-571.
6. Bertucci F, Viens P, Tagett R, Nguyen C, Houlgatte R and Birnbaum D. (2003b). Lab. Invest., 83, 305-316.
7. Bilous M, Dowsett M, Hanna W, Isola J, Lebeau A, Moreno A, Penault-Llorca F, Ruschoff J, Tomasic G and Van De Vijver M. (2003). Mod. Pathol., 16, 173-182.
8. Callagy G, Cattaneo E, Daigo Y, Happerfield L, Bobrow LG, Pharoah PD and Caldas C. (2003). Diagn. Mol. Pathol., 12, 27-34.
9. Dressman MA, Baras A, Malinowski R, Alvis LB, Kwon I, Walz TM and Polymeropoulos MH. (2003). Cancer Res., 63, 2194-2199.
10. Frade R, Balbo M and Barel M. (2002). Oncogene, 21, 861-866.
11. Garratt AN, Ozcelik C and Birchmeier C. (2003). Trends Cardiovasc. Med., 13, 80-86.
12. Gilde AJ and Van Bilsen M. (2003). Acta Physiol. Scand., 178, 425-434.
13. Ginestier C, Charafe-Jauffret E, Bertucci F, Eisinger F, Geneix J, Bechlian D, Conte N, Adélaide J, Toiron Y, Nguyen C, Viens P, Mozziconacci MJ, Houlgatte R, Birnbaum D and Jacquemier J. (2002). Am. J. Pathol., 161, 1223-1233.
14. Ginestier C, Charafe-Jauffret E, Penault-Llorca F, Adélaïde J, Geneix J, Chaffanet M, Mozziconacci MJ, Hassoun J, Birnbaum D and Jacquemier J: J. Pathol., in press.
15. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD and Lander ES. (1999). Science, 286, 531-537.
16. Han J, Lee JD, Jiang Y, Li Z, Feng L and Ulevitch RJ. (1996). J. Biol. Chem., 271, 2886-2891.
17. Hayes DF and Thor AD. (2002). Semin. Oncol., 29, 231-245.
18. Holbro T, Civenni G and Hynes NE. (2003). Exp. Cell Res., 284, 99-110.
19. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, Ringner M, Sauter G, Monni O, Elkahloun A, Kallioniemi OP and Kallioniemi A. (2002). Cancer Res., 62, 6240-6245.
20. Kauraniemi P, Bärlund M, Monni O and Kallioniemi A. (2001). Cancer Res., 61, 8235-8240.
21. Keshgegian AA. (1995). Breast Cancer Res. Treat., 35, 201-210.
22. Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H and Slamon DJ. (2003). J. Natl. Cancer Inst., 95, 142-153.
23. Korsching E, Packeisen J, Agelopoulos K, Eisenacher M, Voss R, Isola J, van Diest PJ, Brandt B, Boecker W and Buerger H. (2002). Lab. Invest., 82, 1525-1533.
24. Kumar-Sinha C, Woods Ignatoski K, Lippman ME, Ethier SP and Chinnaiyan AM. (2003). Cancer Res., 63, 132-139.
25. Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM, Parmacek MS, Soudais C and Leiden JM. (1997). Genes Dev., 11, 1048-1060.
26. Leyland-Jones B. (2002). Lancet Oncol., 3, 137-144.
27. Mackay A, Jones C, Dexter T, la Silva R, Bulmer K, Jones A, Simpson P, Harris RA, Jat PS, Neville AM, Reis LFL, Lakhani SR and O'Hare MJ. (2003). Oncogene, 22, 2680-2688.
28. Magrangeas F, Nasser V, Avet-Loiseau H, Loriod B, Decaux O, Granjeaud S, Bertucci F, Birnbaum D, Nguyen C, Harousseau JL, Bataille R, Houlgatte R and Minvielle S. (2003). Blood, 101, 4998-5006.
29. Oh JJ, Grosshans DR, Wong SG and Slamon DJ. (1999). Nucleic Acids Res., 27, 4008-4017.
30. Patient RK and McGhee JD. (2002). Curr. Opin. Genet. Dev., 12, 416-422.
31. Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R and Slamon DJ. (2000). J. Clin. Oncol., 18, 3651-3664.
32. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO and Botstein D. (2000). Nature, 406, 747-752.
33. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX and Slamon DJ. (1995). Oncogene, 10, 2435-2446.
34. Platzer P, Upender MB, Wislon K, Willis J, Lutterbaugh J, Nosrati A, Willson JKV, mack D, Ried T and Markowitz S. (2002). Cancer Res., 62, 1134-1138.
35. Pollack JR, Sorlie T, Perou CM, Rees CA, Jeffrey SS, Lonning PE, Tibshirani R, Botstein D, Borresen-Dale AL and Brown PO. (2002). Proc. Natl. Acad. Sci. USA, 99, 12963-12968.
36. Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY and Bernstein L. (2002). J. Clin. Oncol., 20, 3095-3105.
37. Rampaul RS, Pinder SE, Gullick WJ, Robertson JF and Ellis IO. (2002). Crit. Rev. Oncol. Hematol., 43, 231-244.
38. Revillion F, Bonneterre J and Peyrat JP. (1998). Eur. J. Cancer, 34, 791-808.
39. Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, Ackerman D, Maurer R, Alund G, Knönagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schönenberger A, Flury R, Jäger P, Fehr JL, Schrami P, Moch H, Mihatsch MJ, Gasser T, Kallioniemi OP and Sauter G. (2000). Am. J. Pathol., 157, 787-794.
40. Sabatti C, Karsten SL and Geschwind DH. (2002). Math. Biosci., 176, 17-34.
41. Shen TL, Han DC and Guan JL. (2002). J. Biol. Chem., 277, 29069-29077.
42. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
43. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P and Borresen-Dale AL. (2001). Proc. Natl. Acad. Sci. USA, 98, 10869-10874.
44. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL and Botstein D. (2003). Proc. Natl. Acad. Sci USA, 100, 8418-8423.
45. Spencer KS, Graus-Porta D, Leng J, Hynes NE and Klemke RL. (2000). J. Cell. Biol., 148, 385-397.
46. Tan M, Yao J and Yu D. (1997). Cancer Res., 57, 1199-1205.
47. Theillet C, Adélaïde J, Louason G, Bonnet-Dorion F, Jacquemier J, Adnane J, Longy M, Katsaros D, Sismondi P, Gaudray P and Birnbaum D. (1993). Genes Chromosomes Cancer, 7, 219-226.
48. Tiwari RK, Mukhopadhyay B, Telang NT and Osborne MP. (1991). Anticancer Res., 11, 1383-1388.
49. Tomasetto C, Regnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P and Rio MC. (1995). Genomics, 28, 367-376.
50. van de Vijver M. (2002). Oncology, 63 (Suppl 1), 33-38.
51. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH and Bernards R. (2002). N. Engl. J. Med., 347, 1999-2009.
52. van't Veer LJ, Dai H, van de Vijver M, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH. (2002). Nature, 415, 530-535.
53. Willis S, Hutchins AM, Hammet F, Ciciulla J, Soo WK, White D, van der Spek P, Henderson MA, Gish K, Venter DJ and Armes JE. (2003). Genes Chromosomes Cancer, 36, 382-392.
54. Wilson KS, Roberts H, Leek R, Harris AL and Geradts J. (2002). Am. J. Pathol., 161, 1171-1185.
55. Yanazume T, Hasegawa K, Wada H, Morimoto T, Abe M, Kawamura T and Sasayama S. (2002). J. Biol. Chem., 277, 8618-8625.
56. Yang RB, Ng CK, Wasserman SM, Colman SD, Shenoy S, Mehraban F, Komuves LG, Tomlinson JE and Topper JN. (2002). J. Biol. Chem., 277, 46364-46373.